US Army Funds Perpetua's $40M Tungsten Feasibility Study at Idaho's Stibnite Project
The timing is not accidental. Tungsten scarcity has been a known constraint since 2024, but the recent signals in prior coverage — Iranian escalation locking in extended Middle East demand, AUKUS submarine rotations reaching IOC in 2027, and Ukrainian drone strikes on Russian petrochemical plants signaling that attrition is the new normal — have compressed the munitions production timeline.
If the U.S. runs a Taiwan contingency scenario in 2029-2030, it will burn through tungsten stocks faster than Chinese export controls can be worked around. A domestic source, even at higher cost, becomes non-negotiable.
The Pentagon is moving tungsten from exploration to production feasibility because the supply chain has no redundancy: China controls export policy on a metal that hardens steel for armor plate, tank rounds, and missile bodies, and the U.S. military has no domestic source to fall back on if Beijing restricts shipments further.
The 36-month timeline puts a production decision at Q4 2029 — exactly when AUKUS munitions ramp-up will be at full throttle and when the Taiwan contingency window tightens. If Stibnite clears permitting and metallurgical test work confirms the 4.6% tungsten grades the article cites, Perpetua will have leverage to demand either accelerated federal permitting or equity financing at a premium — either way, the capital demand lands on either the defense budget or private capital markets just as munitions procurement is competing for both.
Does the Army's feasibility award include a binding production commitment if test work succeeds, or is it purely exploratory funding with no guarantee of scale-up capital? The distinction determines whether this is a real supply-chain hedge or a hedge-fund exercise.
Fault Lines
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.